|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
“Creating New In-Roads for Cancer-Specific T Cells”
If you have a question about this talk, please contact Matt Humphries.
Hosted By: Rahul Roychoudhuri
One limitation to successful cancer immunotherapy is the immunosuppressive effects of Tregs which are highly enriched in many tumours. This talk will focus on the impact of these cells in the context of human colorectal cancer (CRC) and in mouse models of cancer. In the case of CRC , Tregs are associated with disease progression and a paucity of T cell responses to tumour-associated antigens. Modulation of Treg numbers restores these immune responses, possibly leading to control of disease progression. In the case of mouse models, the talk will focus on the impact of Treg on the tumour vasculature. Modulating Treg numbers/activity results in alterations to the vasculature that serve to increase the frequency of tumour-infiltrating T cells and improve control of tumour growth. These findings could inform future therapeutic approaches to increase access of effector cells to the tumour microenvironment.
This talk is part of the Babraham Seminar series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsEuropean Research Seminar Series 2015-2016 Scott Polar Research Institute - Physical Sciences Seminar CU Global Health
Other talks70th Anniversary Celebration Vibrational coherence spectroscopy applied to biomimetic molecular photoswitches The WTF Economy Frogs in space: physiological research into metric relationships and laws of nature Black and British Migration The extreme values of random frequency response functions